ROCKWELL MEDICAL, INC.
30142 S. Wixom Road
Wixom, MI 48393
August 21, 2023
VIA EDGAR
Jimmy McNamara
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Washington, D.C. 20549-3561
Re: Rockwell Medical, Inc.
Registration Statement on Form S-3
File No. 333-273983
Dear Mr. McNamara:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Rockwell Medical, Inc. (the “Company”), hereby requests acceleration of the effective date of the above referenced Registration Statement to 4:00 p.m., Eastern Time, on August 22, 2023, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Gibson, Dunn & Crutcher LLP, requests by telephone that such Registration Statement be declared effective. In making this acceleration request, the Company acknowledges that it is aware of its obligations under the Act.
Please contact Ryan Murr of Gibson, Dunn & Crutcher LLP by telephone at (415) 393-8373 or via email at RMurr@gibsondunn.com as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter. We also respectfully request that a copy of the written order from the Commission verifying the effective time of such Registration Statement be sent to Mr. Murr via email at RMurr@gibsondunn.com.
| Sincerely, | |
| /s/ Mark Strobeck | |
| Name: Mark Strobeck | |
| Title: President and Chief Executive Officer |
cc: Ryan Murr
Gibson, Dunn & Crutcher LLP
